The importance of steroid uptake and intracrine action in endometrial and ovarian cancers

Rižner, T. L. and Thalhammer, T. and Laczka, Csilla (2017) The importance of steroid uptake and intracrine action in endometrial and ovarian cancers. FRONTIERS IN PHARMACOLOGY, 8 (6). pp. 1-22. ISSN 1663-9812

Preview

Text fphar_08_00346_u.pdf Download (1MB) | Preview

Abstract

Endometrial and ovarian cancers predominately affect women after menopause, and are more frequently observed in developed countries. These are considered to be hormone-dependent cancers, as steroid hormones, and estrogens in particular, have roles in their onset and progression. After the production of estrogens in the ovary has ceased, estrogen synthesis occurs in peripheral tissues. This depends on the cellular uptake of estrone-sulfate and dehydroepiandrosterone-sulfate, as the most important steroid precursors in the plasma of postmenopausal women. The uptake through transporter proteins, such as those of the organic anion-transporting polypeptide (OATP) and organic anion-transporter (OAT) families, is followed by the synthesis and action of estradiol E2. Here, we provide an overview of the current understanding of this intracrine action of steroid hormones, which depends on the availability of the steroid precursors and transmembrane transporters for precursor uptake, along with the enzymes for the synthesis of E2. The data is also provided relating to the selected transmembrane transporters from the OATP, OAT, SLC51, and ABC-transporter families, and the enzymes involved in the E2-generating pathways in cancers of the endometrium and ovary. Finally, we discuss these transporters and enzymes as potential drug targets. © 2017 Rižner, Thalhammer and özvegy-Laczka.

Actions (login required)

Edit Item